Log In
Print
BCIQ
Print
Print this Print this
 

carvedilol (EG-P042, RHB-101)

  Manage Alerts
Collapse Summary General Information
Company Egalet Corp.
DescriptionOnce-daily, controlled-release formulation of carvedilol, a non-selective adrenergic receptor beta (ADRB) blocker with adrenergic receptor alpha 1 (ADRA1) blocking activity
Molecular Target Adrenergic receptor beta (ADRB) ; Adrenergic receptor alpha 1 (ADRA1)
Mechanism of ActionAdrenergic receptor alpha 1 (ADRA1) antagonist; Adrenergic receptor beta (ADRB) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today